Study: Early phase of Moderna COVID-19 vaccine trial reveals more about immune response in older adu
VIDEO Now: Pawtuxet River during Wednesday's storm
VIDEO NOW: Governor Raimondo on COVID-19 data, schools
Published on 30 Sep 2020, 10:59
An extension of Moderna's Phase I trial for its COVID-19 vaccine candidate shows promising results in older adults, with side effects reported as "predominantly mild or moderate in severity."
Cruz on Fox Slams Big Tech Censorship & Discusses New Legislation to Stop Dems from Packing SCOTUS
Pennsylvania has been shut down long enough, get your governor to OPEN UP!
Trump, Biden not to discuss foreign policy in final debate
Why Democrats and Republicans have different priorities on COVID relief
Study: COVID-19 pandemic to significantly impact Mass. commute into 2024
Jeffrey Toobin: New Yorker investigates nude Zoom call mishap | USA TODAY
OTR: Was canceling Boston Marathon the right call?
Hunter Biden associate reveals dealings with Russian oligarch
Schumer, Senate Dems hold press conference
Dr. Fauci Stabs President Trump in the Back after This Tasteless Comment During TV Interview
World Series: Dodgers, Rays, who wins?
Maria Ressa and Renée DiResta | TIME100 Talks
DCFPC Briefing "Strategic Outlook on U.S. Coast Guard Pacific Operations and Deterring IUU Fishing"
Pinpoint Weather 12